First described in a paper published 4 years ago, the new Gleason grade group system for the risk classification of prostate cancer (PCa) is now routinely included in PCa pathology reports and commonly used in counseling patients newly diagnosed with the malignancy. Read more read more →

LOWELL — Week after week, the man battling prostate cancer visits the hospital for conventional radiation therapy. The grueling, marathon treatment plan stretches for more than two months. Read more read more →

Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions, experts at Fox Chase Cancer Center say. Read more read more →

Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses precision medicine for patients with metastatic prostate cancer. Read more read more →

“I’ve never understood why men don’t talk about it. A couple of men I know who had prostate cancer, as far as them coming together — nobody talks about it. There are times men are bragging, you know, on this subject, but now it’s just total silence,” says “Joe” (not his real name) of Oxnard,.. read more →

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid, Spain. Read more read more →

DEAR MAYO CLINIC: At what age should I be screened for prostate cancer? I have read different things about the best time to first have it done. Read more read more →

A new imaging technique called oxygen enhanced optoacoustic tomography (OE-OT) may improve the ability to distinguish between aggressive and less-aggressive prostate cancer cases, identifying those patients who can undergo chemo and/or radiation therapy, according to researchers. Read more  read more →

Finding a robust positive predictive biomarker for immunomodulatory drugs is difficult, says Charles Drake, MD, PhD, as the immune tumor microenvironment is so complex. Read more read more →

21 Aug 2017
August 21, 2017

Coping with Cancer Can Wear You Down

0 Comment

For five consecutive days, I dealt with troublesome and life-altering side effects from my most recent surgery, a cholecystectomy. During that time, I learned valuable lessons about coping with cancer, or any chronic disease that affects you every minute of your day and night. It took less than five days for me to reach a place of.. read more →